Just, K.S.; Dormann, H.; Schurig, M.; Böhme, M.; Fracowiak, J.; Steffens, M.; Scholl, C.; Seufferlein, T.; Gräff, I.; Schwab, M.;
et al. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study. J. Clin. Med. 2020, 9, 1801.
https://doi.org/10.3390/jcm9061801
AMA Style
Just KS, Dormann H, Schurig M, Böhme M, Fracowiak J, Steffens M, Scholl C, Seufferlein T, Gräff I, Schwab M,
et al. Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study. Journal of Clinical Medicine. 2020; 9(6):1801.
https://doi.org/10.3390/jcm9061801
Chicago/Turabian Style
Just, Katja S., Harald Dormann, Marlen Schurig, Miriam Böhme, Jochen Fracowiak, Michael Steffens, Catharina Scholl, Thomas Seufferlein, Ingo Gräff, Matthias Schwab,
and et al. 2020. "Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study" Journal of Clinical Medicine 9, no. 6: 1801.
https://doi.org/10.3390/jcm9061801
APA Style
Just, K. S., Dormann, H., Schurig, M., Böhme, M., Fracowiak, J., Steffens, M., Scholl, C., Seufferlein, T., Gräff, I., Schwab, M., & Stingl, J. C.
(2020). Adverse Drug Reactions in the Emergency Department: Is There a Role for Pharmacogenomic Profiles at Risk?—Results from the ADRED Study. Journal of Clinical Medicine, 9(6), 1801.
https://doi.org/10.3390/jcm9061801